ORAMED PHARMACEUTICALS INC. Income Statement
ORMP|10 years of annual SEC 10-K data (FY2016-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
ORAMED PHARMACEUTICALS INC. reported $2M in revenue and $19M in net loss for FY2025. Revenue has grown at a 13.5% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $1.3M | $2.7M | $2.7M | $2.7M | $2.7M | $2.5M | $641.0K | $641.0K | $641.0K |
| Cost of Revenue | $2.0M | - | - | - | - | $90.0K | $187.0K | - | $490.0K | $490.0K |
| Gross Profit | $13.0K | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $6.5M | $8.4M | $13.8M | - | $4.2M | $3.7M | $2.8M | $2.5M | $2.6M | $2.6M |
| R&D Expense | $6.3M | $9.0M | $27.6M | $21.0M | $10.2M | $13.5M | $10.3M | $7.7M | $4.8M | $3.3M |
| Operating Income | -$12.8M | -$15.8M | -$40.6M | -$24.2M | -$11.8M | -$14.6M | -$10.8M | -$10.0M | -$7.4M | -$5.9M |
| Interest Expense | - | $2.6M | $2.0M | - | - | - | - | - | - | - |
| Income Tax | $3.2M | $3.2M | $100.0K | $100.0K | - | $300.0K | $400.0K | $1.3M | -$1.0K | $4.0K |
| Net Income | -$19.1M | $5.1M | -$36.6M | -$23.0M | -$11.5M | -$14.4M | -$10.5M | -$11.0M | -$7.2M | -$5.7M |
| EPS (Basic) | -$0.48 | $0.14 | -$0.94 | $0.78 | - | - | - | - | - | - |
| EPS (Diluted) | -$0.48 | $0.14 | -$0.94 | $0.78 | $0.56 | $0.82 | $0.79 | $0.87 | $0.67 | $0.62 |
| Shares Outstanding | 39.9M | 40.3M | 39.6M | 38.2M | 23.7M | 17.4M | 17.4M | 13.7M | 13.2M | 11.6M |
| Gross Margin | 0.7% | - | - | - | - | - | - | - | - | - |
| Operating Margin | -639.1% | -1176.8% | -1502.0% | -896.1% | -433.8% | -541.3% | -438.6% | -1561.6% | -1151.8% | -921.4% |
| Profit Margin | -953.0% | 379.7% | -1352.6% | -850.5% | -424.8% | -531.1% | -426.7% | -1710.5% | -1128.2% | -888.6% |